共 23 条
- [21] BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria [J]. CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7080 - 7085
- [23] BASELINE LEVELS OF CTX-II AND GLUCOSYL-GALACTOSYL-PYRIDINOLINE IN PATIENTS WIH EARLY PSORIASIC ARTHRITIS: ASSOCIATION WITH DISEASE SEVERITY, DISABILITY, QUALITY-OF-LIFE, BIOLOGICAL TREATMENT REQUIRED AND PROGRESSION OF JOINT DESTRUCTION AT 5 YEARS OF FOLLOW UP [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1153 - 1154